Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 贵州百灵企业集团制药股份有限公司是一家苗药研发、生产企业.其产品主要有咳化痰用药、感冒用药、心脑血管用药等中成药.公司按照拥有发明专利的苗药产品数量和2009年OTC类苗药产品销售额排名统计,位居全国第一,按照拥有药品批准文号的苗药产品数量和2009年单品种苗药销售额排名统计,公司位居全国第二。 | ||||||||||||||||||||||||
Main Business | 以苗药为主的中成药的生产、销售。主要从事止咳化痰用药、感冒用药及心脑血管用药系列中成药等产品的生产与销售,以及其他天然药物和化学药物的研究开发。 | ||||||||||||||||||||||||
Legal Representative | 姜伟 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 陈培 | ||||||||||||||||||||||||
Solicitors | 北斗星律师事务所 | ||||||||||||||||||||||||
Auditors | 天健正信会计师事务所有限公司 | ||||||||||||||||||||||||
Tel No | 0851-33415126 | ||||||||||||||||||||||||
Fax No | 0851-33412296 | ||||||||||||||||||||||||
Website | www.gzbl.com | ||||||||||||||||||||||||
niumin1804@126.com;chenzhibl@126.com;GZBLZQB@163.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 03/06/2010 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ -0.300 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 2.489 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 5.035B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |